BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1763987)

  • 1. Radical radiotherapy for carcinoma of the larynx--Westmead Hospital experience.
    Turner SL; Tiver KW
    Australas Radiol; 1991 Aug; 35(3):242-7. PubMed ID: 1763987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
    Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
    Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
    Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach.
    Sykes AJ; Slevin NJ; Gupta NK; Brewster AE
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1109-15. PubMed ID: 10725620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
    Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of the subglottis. Results of initial radical radiation.
    Warde P; Harwood A; Keane T
    Arch Otolaryngol Head Neck Surg; 1987 Nov; 113(11):1228-9. PubMed ID: 3117073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of accelerated radiotherapy for supraglottic carcinoma: a Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary experience.
    Nakfoor BM; Spiro IJ; Wang CC; Martins P; Montgomery W; Fabian R
    Head Neck; 1998 Aug; 20(5):379-84. PubMed ID: 9663664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of radiotherapy for primary subglottic squamous cell carcinoma.
    Paisley S; Warde PR; O'Sullivan B; Waldron J; Gullane PJ; Payne D; Liu FF; Bayley A; Ringash J; Cummings BJ
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1245-50. PubMed ID: 11955735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2 glottic cancer. Recurrence, salvage, and survival after definitive radiotherapy.
    Howell-Burke D; Peters LJ; Goepfert H; Oswald MJ
    Arch Otolaryngol Head Neck Surg; 1990 Jul; 116(7):830-5. PubMed ID: 2363922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different clinical presentation, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis.
    Van den Bogaert W; Ostyn F; van der Schueren E
    Radiother Oncol; 1983 Nov; 1(2):117-31. PubMed ID: 6680217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
    McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
    Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
    Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of early squamous cell carcinoma of the piriform fossa.
    Jones AS; Wilde A; McRae RD; Phillips DE; Field JK; Husband DG
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):485-90. PubMed ID: 7895378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage surgery after radiation failure in squamous cell carcinoma of the larynx.
    Mercante G; Bacciu A; Banchini L; Moretto E; Oretti G; Ferri T
    B-ENT; 2005; 1(3):107-11. PubMed ID: 16255494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitive radiotherapy for T1-T2 squamous cell carcinoma of pyriform sinus.
    Rabbani A; Amdur RJ; Mancuso AA; Werning JW; Kirwan J; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):351-5. PubMed ID: 18395359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence after radiotherapy for glottic carcinoma.
    Viani L; Stell PM; Dalby JE
    Cancer; 1991 Feb; 67(3):577-84. PubMed ID: 1898708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twice-a-day radiotherapy for T3 squamous cell carcinoma of the glottic larynx.
    Parsons JT; Mendenhall WM; Mancuso AA; Cassisi NJ; Stringer SP; Million RR
    Head Neck; 1989; 11(2):123-8. PubMed ID: 2722488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.